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 ■ INTRODUCTION
Breast cancer is the second most common type of cancer in 
the general population and the most frequent cancer among women 
worldwide, accounting for 30% of new cancer cases each year. 
Breast cancer is also the most common malignant neoplasm among 
women in Brazil (1). It is estimated that in 2018, approximately 
59,700 new cases of breast cancer will occur, corresponding to 
56.33 cases per 100,000 women (1).
Breast cancer has a relatively good prognosis when diagnosed 
and treated promptly. However, in Brazil, breast cancer mortality 
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OBJECTIVES: To evaluate the impact of breast reconstruction after mastectomy on sexual function, body image, 
and depression.
METHODS: This cross-sectional, comparative, controlled study was conducted with 90 women between 18 and 
65 years of age who had undergone either mastectomy alone (mastectomy group, n=30) or mastectomy combined 
with breast reconstruction (mastectomy-reconstruction group, n=30) at least one year prior to the study or who had 
no breast cancer (control group, n=30). Patients were assessed for sexual function, depression, and body image using 
the validated Brazilian-Portuguese versions of the Female Sexual Function Index, the Beck Depression Inventory, and 
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RESULTS: The three groups were homogeneous for age, marital status, body mass index, and education level. The 
women in the mastectomy group reported significantly worse sexual function, greater depressive symptoms, and 
lower body image than those in the mastectomy-reconstruction and control groups. In the mastectomy group, the 
frequency of sexual dysfunction was significantly greater among patients without a marital partner and those with 
a higher level of education than among patients in the other two groups with the same characteristics.
CONCLUSION: Patients who had undergone breast reconstruction after mastectomy reported better sexual function 
and body image and fewer depressive symptoms than patients who had undergone mastectomy alone. Sexual 
dysfunction was associated with the absence of a marital partner and a higher level of education and was more 
frequent in the mastectomy group.
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rates remain high, with 12.1 deaths per 100,000 cases (1). There 
are still a significant number of patients with palpable breast 
lesions at the time of diagnosis, indicating the need to improve 
early diagnosis strategies, which allows physicians to determine 
the correct diagnosis in a timely manner, thus optimizing the 
chances of treatment and reducing breast cancer mortality rates 
(2). Despite the use of conservative techniques, mastectomy is 
performed in approximately 50% of cases for several reasons, 
including diagnosis in advanced tumour stages, tumour position, 
small breast size, multifocal tumour, and patient requests 
(3). Mastectomy is considered one of the most devastating 
treatments from a psychological point of view and affects self-
esteem, femininity, and body image, causing more trauma than 
cancer itself (4).
The quality of life of patients with breast cancer is affected 
by factors such as pain, fear of recurrence, fatigue, depression, 
feelings of decreased femininity and attractiveness, and changes 
in body image, self-esteem, and sexuality (5-7), and these factors 
are especially relevant after mastectomy (8,9). Sexual quality of 
life, considered one of the pillars of overall quality of life, may 
be influenced by episodes of depression and body image disorders 
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(10). The World Health Organization (WHO) recognizes sexual 
dysfunction as a public health problem and recommends research 
on this topic and patient treatment because of its negative impact 
on quality of life, its effects related to self-esteem and interpersonal 
relationships, and its association with frequent emotional distress (7).
Previous studies on the sexual quality of life of women 
diagnosed with breast cancer have found sexual dysfunction rates 
of up to 60% to 70% (7). Breast reconstruction has a positive 
impact on different aspects of quality of life, especially on body 
image among young women, who usually attach great importance 
to body image (11). Breast reconstruction may improve self-esteem 
without increasing the risk of relapse or delaying the diagnosis of 
local recurrence (7).
Thus, the aim of this study was to evaluate the impact of 
breast reconstruction after mastectomy on specific aspects of 
patient quality of life, including sexual function, body image, 
and depression. If the study shows that breast reconstruction after 
mastectomy leads to improved quality of life in the breast cancer 
population, the findings may contribute to the inclusion of breast 
reconstruction procedures in the routine treatment of patients with 
breast cancer in the Brazilian public health system.
 ■ MATERIALS AND METHODS
This cross-sectional, comparative, controlled study was 
approved by the Research Ethics Committee of the Universidade 
Federal de São Paulo (UNIFESP), Brazil (approval number 
2168/08), and was performed in accordance with the ethical 
standards of the 1975 Declaration of Helsinki and its subsequent 
amendments. Written informed consent was obtained from all 
patients prior to their inclusion in the study; patient anonymity 
was assured.
The study was designed to assess aspects of quality of life 
(i.e., sexual function, depression, and body image) in women 
who had either undergone mastectomy alone or mastectomy 
combined with breast reconstruction. Factors regarded as affecting 
the results included no evidence of active disease and the use of 
antidepressants. Information on breast tumour characteristics, such 
as tumour staging, axillary staging, treatments received, and type 
of surgery, is available but was not included in the study because 
the subgroup sample sizes were small, which did not allow for a 
subgroup analysis.
Sixty women who had undergone breast cancer surgery were 
consecutively selected and allocated to one of two groups: the 
mastectomy-reconstruction group (n=30) or the mastectomy group 
(n=30). In addition, 30 women without breast cancer who were 
matched for sociodemographic factors were invited to participate 
in the study (control group; n=30), resulting in a total sample of 90 
participants in the study.
The inclusion criteria were female gender; age between 18 and 
65 years; sexually active status; and previous mastectomy combined 
with immediate or late breast reconstruction (mastectomy-
reconstruction group) or previous mastectomy alone (mastectomy 
group) at least one year prior to the study or no history of breast 
cancer (control group).
All patients were assessed for sexual function, depression, and 
body image using the validated Brazilian-Portuguese versions of 
the Female Sexual Function Index (FSFI), the Beck Depression 
Inventory (BDI), and the Body Dysmorphic Disorder Examination 
(BDDE), respectively.
As described previously (12,13), the Brazilian version of 
the FSFI, a measure of sexual function in women, meets all 
requirements for international validation and shows acceptable 
discriminant validity in the literature, discriminating between 
women with and without sexual dysfunction (12,13). The Brazilian 
version of the FSFI is a brief scale composed of 19 items grouped 
into six domains: desire, arousal, lubrication, orgasm, satisfaction, 
and pain. The FSFI has been successfully applied to assess sexual 
function in different populations (12,13).
According to the literature (14,15), the BDI measures the 
severity of depressive symptoms. As a self-report instrument 
composed of 21 items, the instrument was developed for use with 
psychiatric patients but has been widely used in clinical practice and 
research with non-psychiatric patients and in the general population. 
The BDI has been translated into several languages and validated in 
different countries. Based on BDI scores, depression can be rated 
as minimum (scores 0-9), light (scores 10-16), moderate (scores 
17-29), or severe (scores 30-63).
The BDDE was used for the evaluation of body image. 
As reported in previous studies (16), the BDDE is a specific 
34-item questionnaire that measures the degree of dissatisfaction 
with a particular part of the body, contributing to the diagnosis of 
body dysmorphic disorders. A total score is calculated as the sum 
of the ratings for all items, except items 1 to 3, 22, 33, and 34, for a 
maximum score of 168. A cutoff score of 66 or more indicates some 
degree of dissatisfaction with one’s appearance.
The questionnaires were administered in the form of interviews 
during routine visits in the breast cancer and plastic surgery 
outpatient clinics of a university hospital.
Statistical analysis
A Kruskal-Wallis analysis of variance was performed to 
compare age and BDDE scores among the groups. A chi-square 
test was carried out to compare the qualitative variables among the 
groups. The Mann-Whitney test was applied to compare the mean 
BDI scores, weight and education level between patients with or 
without sexual dysfunction.
The Statistical Package for the Social Sciences version 18.0 
(SPSS Inc., Chicago, IL, USA) was used for data analysis. All 
statistical tests were performed at a significance level α of 0.05 or 
5% (p<0.05).
 ■ RESULTS
The groups were homogeneous for age (p=0.49), marital status 
(p=0.24), body mass index (BMI; p=0.92), and education level 
(p=0.08), as shown in Table 1.
The mean age of patients in the mastectomy group was 48 years 
(median, 49.7), and 53% of the women were between 48 and 
65 years of age.
Women who had undergone mastectomy alone showed a 
significantly lower (p=0.007) total FSFI score (median, 15.4) than 
women who had undergone mastectomy combined with breast 
reconstruction (median, 21.9) and women in the control group 
(median, 23.6), as well as significantly lower FSFI scores in all 
domains, except the lubrication and satisfaction domains (Table 2).
A non-significant trend (p=0.053) towards a higher 
absolute frequency in sexual dysfunction was observed in the 
mastectomy group (frequency, 23/30) compared to both the 
mastectomy-reconstruction (frequency, 15/30) and control 
(frequency, 15/30) groups.
Most patients in the three groups had a marital partner. However, 
among those without a marital partner, the frequency of sexual 
dysfunction was significantly higher in the mastectomy group than in 
the mastectomy-reconstruction and control groups (p=0.04).
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The frequency of sexual dysfunction was also significantly 
greater among patients with a higher level of education in 
the mastectomy group (frequency, 13/15; p=0.03) than in the 
other groups.
Menopausal women aged 48 to 65 years in the mastectomy 
group had significantly lower FSFI scores than those in the 
mastectomy-reconstruction and control groups (p=0.002).
Patients in the mastectomy group reported significantly higher 
BDI scores (median, 11.1), indicating that these patients had 
more depressive symptoms than patients in the other two groups 
(p=0.02). A comparison among groups of patients 18-47 and 48-63 
years of age showed that younger women in the mastectomy group 
had the highest BDI scores (p=0.04).
Patients in the mastectomy group also showed higher BDDE 
scores (lower body image) than the other subjects (p=0.001), 
although only one patient in the mastectomy group had a BDDE 
score of 67, which is above the cutoff score (cutoff score = 66) 
characterizing actual dissatisfaction with body image (Table 3).
 ■ DISCUSSION
The diagnosis and treatment of breast cancer result in significant 
psychological distress, contributing to a negative perception of 
quality of life. Physical changes such as impaired mobility and 
upper limb lymphedema, chemotherapy, vasomotor symptoms, 
vaginal dryness, and sexual dysfunctions may also affect the quality 
of life of these women (8,17).
Aesthetic standards defining a woman as sensual and 
attractive change over time. Breasts not only play an important 
physiological role in some phases of a woman’s life but also 
represent a cultural symbol of femininity, sensuality, and sexuality. 
When a woman undergoes mastectomy for the treatment of breast 
cancer, she experiences disruption of the harmony of the “perfect 
body”, which becomes “imperfect”, leading to several problems 
involving sexuality, psychological structure, self-concept, and 
self-image (18,19).
The increasing number of women with breast cancer may be 
attributed to decreasing mortality rates, increasing rates of early 
detection, improved treatments, and increasing incidence of new 
cases of breast cancer in the last decade. Approximately 61% of 
patients with breast cancer will survive after 5 years of diagnosis, 
and approximately 50% of patients worldwide will survive for at 
least 15 years after diagnosis (1). These women should receive 
Table 1 – Sociodemographic characteristics of the patients.
Variables
Groups
p-value
Control Mastectomy Reconstruction
Mean age (years) 47.0 48.0 47.5 0.49
Education level (%)
<8 years 40.0 46.4 20.0
0.08
 ≥8 years 60.0 53.6 80.0
Marital partner
Yes 76.6 66.6 56.7
0.24
No 23.4 33.4 43.3
Chemotherapy (%)
Yes _ 66.5 73.3
0.77
No _ 33.3 27.7
BMI (%)
18-25 29.1 30.7 40.7
0.9225-30 45.9 50.0 48.1
≥30 25.0 19.3 11.2
BMI: body mass index; Reconstruction: mastectomy-reconstruction group.
Table 2 – Median scores on the Female Sexual Function 
Index (FSFI).
Domains
Groups
p-value
Control Mastectomy Reconstruction
Desire 3.0 2.2 3.3 0.006*
Arousal 3.3 2.0 3.9 0.010*
Lubrification 4.0 3.0 4.5 0.090
Orgasm 4.8 2.0 4.6 0.010*
Satisfaction 4.8 4.0 4.8 0.080
Pain 5.6 3.2 3.4 0.004*
Total score 23.6 15.4 21.9 0.007*
Reconstruction: mastectomy-reconstruction group.
Kruskal-Wallis test.
* Statistical significance (p<0.05).
Table 3 – Median Beck Depression Inventory (BDI) and 
Body Dysmorphic Disorder Examination (BDDE) scores for 
the three groups.
Scales
Groups
p-value
Control Mastectomy Reconstruction
BDI 5. 3 11.1 3.0 0.02*
BDDE 10.0 29.5 10.0 0.01*
Reconstruction: mastectomy-reconstruction group.
Kruskal-Wallis test.
* Statistical significance (p<0.05).
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support for their psychological adjustment after the surgical 
treatment of breast cancer (17). Previous studies have shown that 
the overall quality of life of patients treated for breast cancer, when 
free from disease, is similar to that of women without breast cancer 
(20) but with clinically significant differences in cognitive and 
functional status, fatigue, insomnia, and financial issues (21).
Relationship quality seems to be an important determinant 
of sexual function in women with breast cancer and can interfere 
with the physiological process of excitation, lubrication, orgasm, 
and satisfaction (8). In the present study, the frequency of sexual 
dysfunction among patients without a marital partner was 
significantly higher in the mastectomy group than in the other groups, 
but no significant differences in sexual dysfunction between the 
groups were observed among patients who had a marital relationship.
An elapsed time ≥1 year between surgery (mastectomy or breast 
reconstruction) and inclusion in this study was considered adequate 
to reduce the physical and psychological impact associated with the 
surgical procedure itself.
The authors acknowledge the limitation of conducting a 
retrospective study, but the homogeneity of the sociodemographic 
characteristics of the participants and the inclusion of a control 
group composed of healthy women contributed to making the 
results reliable and meaningful (22).
Breast reconstruction is an oncologically safe procedure 
that improves the patient’s self-esteem without increasing the 
risk of relapse or delaying the diagnosis of local recurrence (7). 
The reconstruction of the breast after mastectomy may preserve 
a woman’s self-concept and improve her body image (23) and 
quality of life, resulting in a less traumatic rehabilitation process 
compared to that for mastectomy alone (24), especially among 
younger women, who give greater importance to body image than 
older women (25).
Adequate sexual function is an important factor in the overall 
quality of life and life satisfaction. Considering the barriers to 
discussing sexual function, the use of a validated, reliable, easy-
to-use scale for assessing sexual dysfunction can be helpful for 
evaluating outcomes and side effects of breast cancer treatments 
(26). The FSFI was chosen for the study because it is a tool widely 
used for assessing breast cancer patients in clinical and research 
settings. A recently published breast cancer-specific version of the 
FSFI (FSFI-BC) addresses topics not included in the FSFI, such as 
the assessment of sexual function in sexually non-active women 
(27). However, this version has not yet been cross-culturally 
validated for use in Brazil.
In this study, a trend towards higher education level was 
observed among patients in the mastectomy-reconstruction group, 
suggesting that women with higher education may be more sensitive 
to body image changes resulting from mastectomy, possibly due 
to the demands of their active social and professional lives (28). 
Patients who had undergone breast reconstruction reported sexual 
function similar to that of the controls and significantly higher than 
that of patients who had undergone mastectomy alone, which is 
consistent with previous studies (27). No significant differences in 
sexual dysfunction were found among younger patients in the three 
groups, contrasting with other research findings (27).
Patients in the mastectomy group had a median age of 
49.7 years, and the majority of them were between 48 and 65 years. 
According to epidemiological data, menopause occurs in Brazilian 
women around 51 years of age (29). Considering that female life 
expectancy in Brazil is 72.4 years, one-third of women’s lives 
will be spent in the menopausal transition (40-65 years of age) 
between reproductive life and menopause (29). The menopausal 
transition alone does not diminish sexual interest but affects the 
sexual response (excitement phase), which becomes slower and 
more intense because of oestrogen deprivation. The orgasmic phase 
becomes shorter, and pain is more frequent due to genital atrophy. 
Our results showed a decrease in sexual function among women 
48 to 65 years of age, including the controls, which is consistent 
with the findings of other authors reporting on increased sexual 
dysfunction during the menopausal transition (30).
Patients from 18 to 47 years of age reported better sexual function 
than older patients, without significant differences between the groups. 
However, it is interesting to note that patients in the mastectomy group 
had a median total FSFI score <26, which is indicative of sexual 
dysfunction, showing how mastectomy and a possible decrease in 
ovarian function due to chemotherapy affect sexual function (31). Low 
FSFI scores in young patients who had undergone mastectomy have 
also been reported by other authors (31-33).
Overall, patients in the mastectomy group showed more 
depressive symptoms than patients in the other two groups, which 
was in agreement with previous studies using the BDI to assess 
women treated for breast cancer (6). Changes in physical appearance 
resulting from radical surgical procedures for the treatment of breast 
cancer are one of the most frequent causes of depression and low 
self-concept among this population, usually because patients feel 
less sexually attractive and less feminine (6). Depressive symptoms 
were more frequent among younger patients aged 18 to 47 years, 
showing that the combination of age and history of depression may 
be an important predictor of depression in this age group (32).
In this series, no significant correlation was observed between 
sexual dysfunction and depression, although increased depressive 
symptoms were observed in patients with sexual dysfunction, 
especially in the mastectomy group. Patients in the mastectomy group 
also reported worse body image than other subjects, suggesting that 
changes in physical appearance caused by the surgical treatment may 
affect sexual dysfunction. Previous studies have also reported poor 
body image among patients who had undergone mastectomy (34,35). 
In contrast, patients who had undergone breast reconstruction after 
mastectomy reported body image satisfaction similar to that of 
women in the control group, highlighting the positive impact of 
breast reconstruction on body image.
Although the study design did not allow an analysis of the 
impact of breast reconstruction on the quality of life of patients, it 
permitted the assessment of sexual function and associated factors, 
such as body image and depression, in a group of patients who 
had undergone breast reconstruction, and the results of the study 
showed the importance of personal characteristics, such as marital 
status, education level, and age.
The assessment of sexual function in women who lost their 
breast as a result of cancer treatment is an important and integral 
part of patient follow-up. Sexual function assessment should also 
be included in the evaluation of the effectiveness of different 
treatments for breast cancer.
Breast cancer is considered a chronic disease, with increasing 
incidence in recent decades. Improved diagnostic methods and less 
aggressive surgical treatments increase survival time and enhance 
the quality of survival. It is necessary and important to evaluate the 
patient’s quality of survival and quality of life, focusing on factors 
such as sexuality, body image, and depression. The assessment of 
these factors and their impact on patient quality of life allows the 
implementation of support measures by a multidisciplinary team, 
the identification of at-risk patients, and tailored treatment based on 
the assessment results.
A cross-sectional design provides the opportunity to assess 
patients with different treatment times whose evaluation would be 
more difficult in a prospective study. However, we acknowledge 
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that a prospective design would be more appropriate to evaluate 
the impact of mastectomy combined or not combined with breast 
reconstruction on the quality of life of patients, and this may be 
considered a limitation of the study. Small subgroup sample sizes 
in terms of tumour characteristics were also a limitation that 
prevented some subgroup analyses. Further studies that include 
more patients, utilize a prospective design, and involve multiple 
centres are necessary to extend our results.
 ■ CONCLUSION
Patients who had undergone breast reconstruction after 
mastectomy reported better sexual function, better body image, 
and fewer depressive symptoms than patients who had undergone 
mastectomy alone. The results also showed that sexual dysfunction 
was associated with the absence of a marital partner and a higher 
level of education and was more frequent in the mastectomy group.
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